The global pet calming products market is expected to be valued at US$ 456.6 million in 2026 and projected to reach US$ 818.7 million by 2033, growing at a CAGR of 8.7% between 2026 and 2033.

Market expansion is supported by rising pet ownership, increasing awareness of animal mental health, and higher expenditure on premium pet care products. According to the American Pet Products Association, U.S. pet industry spending exceeded US$ 147 billion in 2023, indicating strong consumer commitment toward pet wellness. Veterinary recommendations addressing separation anxiety, noise phobia, and travel-related stress are also increasing adoption of calming treats, supplements, collars, and sprays across both developed and emerging pet care markets.

Drivers - Rising Pet Humanization and Anxiety Awareness Among Owners

Pet humanization, the practice of treating companion animals as family members, remains a foundational driver for the pet calming products market. A 2023 survey by the American Veterinary Medical Association found that more than 67% of U.S. households own a pet, while dogs and cats collectively account for over 185 million animals. As owners increasingly recognize symptoms such as anxiety, destructive behavior, excessive barking, and aggression, demand for non-pharmaceutical calming aids has expanded significantly across multiple product categories and retail channels worldwide.

Veterinary endorsements of natural compounds, including L-theanine, melatonin, and cannabidiol (CBD), have further widened product acceptance among pet owners. Millennial consumers, in particular, demonstrate a strong preference for preventive, supplement-based wellness management rather than prescription drugs. This shift in consumer behavior continues to support the adoption of calming treats, supplements, collars, and sprays, thereby strengthening long-term market growth prospects and encouraging manufacturers to develop more specialized formulations for anxiety management in companion animals.

E-Commerce Expansion Driving Pet Wellness Product Accessibility

The rapid expansion of online retail has materially increased the market reach of pet calming products worldwide. Major platforms such as Chewy, Amazon, and brand-specific direct-to-consumer websites now account for a growing share of specialty pet product sales. According to Statista, online pet care product sales in the United States exceeded US$ 30 billion in 2023, reflecting the increasing importance of digital retail channels.

Subscription models, auto-ship programs, and targeted digital marketing through social media influencers are accelerating trial rates for calming chews, sprays, and diffusers. Platforms such as Instagram, TikTok, and YouTube have become important channels for engaging pet parent communities, supporting brand loyalty, and encouraging repeat purchases of pet wellness products. These digital strategies also enable manufacturers to collect consumer insights, personalize offerings, and strengthen long-term customer relationships through data-driven marketing initiatives.

Restraints - Regulatory Ambiguity Limiting CBD-Based Pet Product Commercialization

Despite strong consumer interest, the regulatory status of cannabidiol (CBD) in pet products remains unresolved in several jurisdictions. The U.S. Food and Drug Administration has not approved any CBD-infused pet food or supplement products to date and has repeatedly cautioned consumers against assuming they are safe. This regulatory uncertainty creates compliance challenges for manufacturers and limits shelf placement opportunities in major retail chains, thereby restricting broader commercialization efforts across several regional markets.

In addition, the absence of clear regulatory pathways increases liability exposure for companies developing CBD-based calming formulations. Similar regulatory gaps persist in the European Union under the European Food Safety Authority framework, restricting market-access pathways for novel calming formulations. These unresolved regulatory conditions continue to slow the broader commercialization of CBD-based pet wellness products and create uncertainty for manufacturers planning long-term investment and product development strategies.

Price Sensitivity Restricting Premium Calming Product Adoption

Premium calming products containing functional ingredients such as valerian root, alpha-casozepine, or tryptophan often carry higher price points, limiting adoption among cost-conscious pet owners. In price-sensitive markets across Latin America, South Asia, and parts of Southeast Asia, limited disposable income reduces willingness to spend on non-essential pet wellness supplements. This economic barrier restricts broader market penetration and slows the adoption of premium calming solutions among middle-income households in emerging economies.

Furthermore, some veterinary practitioners remain cautious about recommending over-the-counter calming products that lack robust clinical trial data. This hesitation restricts uptake through clinical referral pathways and limits the credibility of certain product categories. As a result, manufacturers seeking to expand adoption of premium calming solutions must invest in stronger scientific validation and evidence-based marketing to gain wider acceptance among veterinary professionals and consumers.

Opportunities - Functional Nutrition Trends Boosting Calming Chew Demand

Calming chews represent the fastest-growing product format within the pet calming products market, supported by the broader shift toward functional pet nutrition. The Pet Food Institute reports increasing consumer demand for soft, palatable, multi-benefit chews that combine calming effects with joint support, digestive health, and coat conditioning. This trend is encouraging manufacturers to develop more comprehensive wellness-oriented formulations that address multiple health concerns through a single product offering.

Companies that co-develop chew formulations with veterinary nutritionists can position their products as evidence-backed functional foods rather than conventional supplements. Product launches featuring clinically validated dosing of GABA, ashwagandha, and chamomile extracts are expected to command premium pricing. These innovations also help manufacturers expand their addressable market through the convergence of nutrition and behavioral health, creating stronger differentiation in an increasingly competitive pet wellness industry.

Emerging Markets Present Significant Calming Product Growth Potential

Asia Pacific, particularly China, Japan, and South Korea, is experiencing a structural shift toward companion animal ownership driven by urbanization and changing household demographics. China’s pet industry revenues surpassed CNY 260 billion in 2023, according to the China Pet Industry White Paper. First-generation urban pet owners in these markets are increasingly receptive to premium wellness solutions and specialized pet care products.

However, calming product penetration rates remain significantly below those observed in North America and Western Europe. Companies entering these regions with localized formulations, such as herbal-based calming sprays compliant with ASEAN regulatory standards or Japan’s Ministry of Agriculture, Forestry and Fisheries guidelines, are positioned to capture first-mover advantages in these high-growth emerging markets and establish stronger brand recognition before competition intensifies.

Product Type Analysis

Calming treats lead the product type category, commanding an estimated 35% of the global pet calming products market in 2026. Their dominance stems from ease of administration: pet owners can introduce treats as part of a daily routine without veterinary guidance, lowering the barrier to trial. The format benefits from wide retail availability across pet specialty stores, online platforms, and general merchandise channels. According to the Association of American Feed Control Officials, most calming treat formulations now incorporate GRAS ingredients such as melatonin, chamomile, and thiamine, making regulatory compliance relatively straightforward.

Calming chews are the fastest-growing product type, supported by the broader shift toward functional pet nutrition. Manufacturers are increasingly developing chew formulations that combine calming effects with joint support, digestive health, and coat conditioning benefits. Their palatable texture, convenient dosing, and ability to incorporate clinically validated ingredients such as GABA, ashwagandha, and chamomile extracts are encouraging higher adoption among pet owners seeking multi-benefit wellness solutions for companion animals.

Pet Type Analysis

Dogs represent the leading segment within the pet type category, accounting for an estimated 58% of global pet calming product demand in 2026. Dogs are significantly more likely than cats to exhibit diagnosable anxiety behaviors, including separation anxiety, noise sensitivity, and thunderstorm phobia, creating a broader clinical and commercial use case for calming interventions. The American Veterinary Medical Association estimates that 13-18% of dogs in the U.S. display clinically notable separation anxiety, translating to tens of millions of potential end users.

Cats are the fastest-growing pet type segment, driven by increasing awareness of feline anxiety and behavioral health. Urban pet owners are becoming more attentive to stress-related conditions in cats, including travel anxiety, environmental changes, and socialization challenges. This trend is encouraging manufacturers to develop species-specific calming products, such as pheromone diffusers, sprays, and supplements, designed to address the unique behavioral needs of feline companions.

Distribution Channel Analysis

Online retail is the leading distribution channel for pet calming products, capturing an estimated 38% of global market share in 2026. The channel’s dominance is driven by convenience, product variety, consumer review ecosystems, and competitive pricing enabled by direct-to-consumer models. Subscription auto-ship programs offered by platforms such as Chewy and Amazon reduce purchase friction and drive repeat purchase rates for calming treats, chews, and supplements.

Veterinary clinics are the fastest-growing distribution channel as pet owners increasingly seek professional guidance for anxiety management. Veterinarians play a critical role in recommending evidence-backed calming products, particularly for pets with severe separation anxiety, noise phobia, or travel-related stress. The growing integration of behavioral health consultations into veterinary care is likely to strengthen the credibility and adoption of clinically supported calming solutions.

North America Pet Calming Products Market Trends and Insights

North America dominates the global pet calming products market with an estimated 41% revenue share in 2026, supported by a mature pet ownership culture, established retail infrastructure, and high per-capita spending on pet wellness. The region leads in product innovation, particularly in functional chew formats incorporating clinical-grade ingredients. Ongoing regulatory engagement with the U.S. Food and Drug Administration on CBD labeling standards continues to influence product development strategies across the United States and Canada, shaping the future direction of calming product formulations and market positioning.

U.S. Pet Calming Products Market Trends and Insights

United States accounts for an estimated 79% of North America’s pet calming products market revenue in 2026, making it the single largest national market globally. Driven by more than 90 million pet-owning households and growing veterinary adoption of non-pharmaceutical anxiety management protocols, U.S. demand for calming treats, chews, and supplements continues to set global benchmarks for category development. Strong consumer willingness to invest in premium pet wellness products, combined with extensive retail and e-commerce distribution networks, further reinforces the country’s leadership position in the global pet calming products industry and supports sustained long-term demand.

Europe Pet Calming Products Market Trends and Insights

Europe represents the second-largest regional market, capturing an estimated 29% of global pet calming products revenue in 2026. The market is supported by strong pet ownership in Germany, France, and the United Kingdom. Regulatory oversight by the European Medicines Agency and country-level agencies shapes product ingredient standards across the region. Consumer preference for natural and organic calming formulations, alongside rising veterinary consultation rates, continues to support premiumization and repeat purchases in European pet wellness markets.

Germany Pet Calming Products Market Trends and Insights

Germany holds the largest national share within the European pet calming products market, contributing an estimated 23% of regional revenues in 2026. With more than 34 million pets and a well-established veterinary prescription culture, Germany’s market is weighted toward diffuser and collar formats featuring clinically validated pheromone technology. Growing consumer awareness of pet mental health is driving repeat purchases through both specialty retail and online channels. The country’s strong regulatory framework and high demand for veterinarian-recommended products continue to reinforce its leadership position within the European market and encourage ongoing product innovation.

U.K. Pet Calming Products Market Trends and Insights

The United Kingdom accounts for an estimated 19% of the European pet calming products market in 2026. Post-pandemic pet adoption, particularly the documented surge in dog ownership during 2020-2021, has translated into sustained demand for separation anxiety products. Adaptil pheromone collars and sprays remain among the best-selling SKUs in U.K. veterinary clinics and pet specialty retail chains. Strong consumer trust in veterinary recommendations and premium pet wellness brands continues to support the expansion of calming product adoption across the country and strengthen repeat purchasing behavior.

France Pet Calming Products Market Trends and Insights

France contributes an estimated 16% of the European pet calming products market in 2026. French pet owners strongly prefer veterinarian-recommended calming solutions, while the country’s regulatory framework under the Agence Nationale du Médicament Vétérinaire supports premium product positioning. Herbal supplement-based calming products are gaining traction in urban markets, particularly among consumers seeking natural wellness alternatives for companion animals. This growing preference for evidence-backed and veterinarian-endorsed formulations continues to strengthen France’s position within the European pet calming products industry and encourage premium product adoption.

Asia Pacific Pet Calming Products Market Trends and Insights

Asia Pacific is the fastest-growing regional market, accounting for an estimated 22% of global pet calming products revenue in 2026. Growth is propelled by accelerating pet ownership in China, Japan, South Korea, and India. The region is transitioning from basic pet nutrition to premium wellness products, with calming treats and supplements gaining visibility through domestic e-commerce platforms such as Tmall, JD.com, and regional social commerce channels.

India Pet Calming Products Market Trends and Insights

India is an emerging market for pet calming products, accounting for an estimated 7% of Asia Pacific pet calming products revenue in 2026. Pet adoption has expanded rapidly in recent years, particularly in urban centers such as Mumbai, Bengaluru, and Delhi. Demand for premium treats and herbal supplements is increasing through specialty pet retail and online channels. Rising awareness of pet behavioral health, combined with higher disposable incomes among urban pet owners, is expected to accelerate the adoption of calming products across the Indian market.

Japan Pet Calming Products Market Trends and Insights

Japan is a mature companion animal market, holding an estimated 13% of Asia Pacific pet calming products revenue in 2026. Calming products, particularly aromatherapy diffusers and pheromone-based collars, are well integrated into pet care routines nationwide. Regulatory standards under the Ministry of Agriculture, Forestry and Fisheries ensure product safety compliance, while local brands compete alongside imported premium formulations in specialty pet stores and national pharmacy chains. Japan’s established pet wellness culture continues to support stable demand for high-quality calming solutions and premium veterinarian-recommended products.

Southeast Asia Pet Calming Products Market Trends and Insights

Southeast Asia contributes an estimated 9% of Asia Pacific pet calming products revenue in 2026, spanning Thailand, Indonesia, Vietnam, and the Philippines. Rising middle-class pet ownership, particularly in urban Thailand and Indonesia, is fueling introductory-level demand for calming treats and sprays. Regional distribution is predominantly channeled through online marketplaces such as Lazada and Shopee, which are expanding consumer access to pet wellness products across the region.

The global pet calming products market remains moderately fragmented, characterized by the presence of multinational pet health companies, specialty nutraceutical firms, and emerging direct-to-consumer brands. Market participants compete through proprietary formulations, veterinary partnerships, and clinical validation of ingredient efficacy, which help strengthen product credibility and consumer trust. Distribution strategies vary across veterinary clinics, specialty retail stores, and rapidly expanding e-commerce platforms.

Companies are increasingly focusing on premium product development, evidence-backed formulations, and brand differentiation to capture a larger customer base. In addition, mergers, acquisitions, and co-branding initiatives with veterinary clinics are emerging as important growth strategies, supporting gradual consolidation within the premium segment of the pet calming products market.

Key Developments:

• In March 2025, CEVA Santé Animale announced expansion of its Adaptil pheromone product line with a new calming chew SKU targeting separation anxiety in dogs, set for phased rollout across North America and Western Europe.
• In November 2024, Zesty Paws launched its reformulated Advanced Calming Bites for dogs, featuring an updated blend of L-theanine, melatonin, and organic ashwagandha, supported by a pilot clinical validation study at a U.S. veterinary school.
• In July 2024, Vetoquinol expanded distribution of Zylkene alpha-casozepine supplements into the Asia Pacific market, entering partnerships with veterinary distributor networks in Japan and Australia.